3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
Primary and study completion pushed from May 26, 2027 to Jun 30, 2028
ShionogiPhase 1 NCT07093580 Registry history of NCT07093580 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 34 → 37 locations
And 1 more change in the last 30 days
ShionogiPhase 3 NCT07743580 Registry history of NCT07743580 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 84 → 87 locations
ShionogiPhase 2 NCT07214571 Registry history of NCT07214571 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-05 | NCT07857837 Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy… | Phase 1 | Not Yet Recruiting |
| Phase 1 | 3 | |
| Phase 1/2 | 2 | |
| Phase 2 | 5 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07743580 | A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are… | SARS-CoV-2 | Recruiting | 2026-10-09 |
| NCT07746544 | Study of Secutrelvir in Participants With COVID-19 | COVID-19 | Recruiting | 2026-09-02 |
| Phase 2 | ||||
| NCT07214571 | A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial… | Respiratory Syncytial Virus Infections | Recruiting | 2026-09-29 |
| NCT07123155 | Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With… | Pompe Disease | Recruiting | 2026-06-23 |
| NCT07750990 | An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD) | Pompe Disease | Not Yet Recruiting | 2026-10-13 |
| NCT06717438 | Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder… | Jordan's Syndrome | Active, Not Recruiting | 2026-06-09 |
| NCT06776432 | Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea | Sleep Apnea | Active, Not Recruiting | 2026-05-06 |
| Phase 1/2 | ||||
| NCT05588323 | Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving… | Opioid-Induced Constipation (OIC) | Recruiting | 2026-07-28 |
| NCT05101070 | S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in… | Solid Tumors | Recruiting | 2026-03-18 |
| Phase 1 | ||||
| NCT07093580 | Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants | Healthy Participants | Recruiting | 2026-10-06 |
| NCT07857837 | Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy… | Renal Impairment | Not Yet Recruiting | 2026-10-05 |
| NCT07787650 | A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD) | Pompe Disease | Not Yet Recruiting | 2026-08-26 |